Anika Therapeutics Inc
Research Anika Therapeutics Inc (ANIK) on Bullrun: market cap USD 286.40M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerANIK
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 286.40M
- Financial periodQ2 2026
- RevenueUSD 32.61M
- Net incomeUSD 3.31M
- Free cash flow-USD 2.13M
- Gross margin65.1%
Valuation Snapshot
latest market cap is USD 286.40M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 112.82M | -USD 11.00M | USD 4.36M | 56.6% | -0.76 | USD 57.48M | USD 26.25M | USD 143.47M |
| FY2024 | USD 119.91M | -USD 56.00M | -USD 2.33M | 63.4% | -3.83 | USD 55.63M | USD 25.93M | USD 153.99M |
| FY2023 | USD 120.79M | -USD 83.00M | -USD 7.22M | 68.3% | -5.64 | USD 68.74M | USD 27.74M | USD 212.27M |
| FY2022 | USD 113.83M | -USD 15.00M | -USD 3.08M | 64.3% | -1.02 | USD 86.33M | USD 29.73M | USD 285.56M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 286.40M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 133.47M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 237.29M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 331.76M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 432.45M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 517.42M | 128.0 | n/a | n/a |
About Anika Therapeutics Inc
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Anika Therapeutics Inc's market cap?
Anika Therapeutics Inc's market capitalization is USD 286.40M.
What does Anika Therapeutics Inc do?
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.